Fierce Healthcare March 28, 2024
Pelago, a virtual substance use disorder (SUD) clinic working with payers and employers, has clinched $58 million in a series C round.
The company will use the capital to expand its programs across the continuum of care, particularly for earlier stages, advance its clinical research efforts and explore expansions into additional substance areas. New investors included Eight Roads and GreyMatter Capital, alongside existing investors Atomico, Kinnevik AB, Octopus Ventures and Y Combinator.
Pelago offers integrated SUD management for employers and payers with specialized treatment for tobacco, alcohol and opioid use disorders. It also began supporting teens ages 15-17 years in all three areas in 2023.
“Pelago’s ability to expand and accelerate access to best-in-class substance use care results in a...
Today's Sponsors
Today's Sponsor